Welcome to our dedicated page for Univ Health Svc SEC filings (Ticker: UHS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Medicare reimbursement tables, patient-day counts, and behavioral health margins scatter across hundreds of pages in Universal Health Services’ disclosures—finding them is a real challenge. If you have ever asked, “Where can I see UHS’s payer mix breakdown?” or “How do I track Universal Health Services insider trading Form 4 transactions?”, you know the pain of combing through technical exhibits.
Stock Titan solves this complexity. Our platform streams every UHS filing from EDGAR the moment it posts and layers AI-powered summaries that explain the implications in plain language. Whether you need the UHS quarterly earnings report 10-Q filing, a freshly issued 8-K material events explained, or the full Universal Health Services annual report 10-K simplified, we highlight the sections that matter—reimbursement risk, malpractice reserves, occupancy trends, and acquisition costs—so you can focus on decisions, not page counts.
Navigate filings the way professionals do:
- One-click access to UHS Form 4 insider transactions real-time and alerts on UHS executive stock transactions Form 4
- Clear dashboards comparing service-line revenue across quarters with our Universal Health Services earnings report filing analysis
- Concise overviews of director pay and governance inside every UHS proxy statement executive compensation
- Contextual summaries that make UHS SEC filings explained simply—ideal for analysts, clinicians, or credit desks
Stop scrolling through PDFs. With Stock Titan you get understanding UHS SEC documents with AI, real-time updates, and the depth healthcare investors require—all in one intuitive space.
Universal Health Services (UHS) reported stronger third‑quarter results. Net revenues were $4,495,245,000, up from $3,963,027,000 a year ago. Income from operations rose to $521,688,000 from $384,165,000. Net income attributable to UHS increased to $372,957,000, and diluted EPS was $5.86 versus $3.80 last year, reflecting improved operating performance across the business.
For the first nine months of 2025, net revenues reached $12,878,781,000 and diluted EPS was $16.07. The balance sheet showed total assets of $15,343,924,000, cash and cash equivalents of $112,895,000, and total debt carrying value of about $4.7 billion. Near‑term liquidity includes a revolving credit facility with approximately $965 million of available capacity as of September 30, 2025. Current maturities of long‑term debt were $740,186,000, highlighting upcoming obligations. Operating cash flow for the nine months was $1,289,704,000, funding $733,932,000 of capital additions and $615,941,000 of share repurchases.
Universal Health Services (UHS)8,425 Class B shares at $138.8 and 9,465 shares at $152.68 (transaction code M), converting derivatives into common stock.
To satisfy tax obligations, 14,312 shares were withheld at $225.15 (code F). Following these transactions, he directly owned 19,957.5817 Class B shares. The options exercised had vested ratably on 3/17/2022, 3/17/2023, 3/17/2024, and 3/17/2025, and 0 derivative securities remained after the transactions. Holdings include 583.5817 shares acquired through the company’s 2005 Employee Stock Purchase Plan.
Universal Health Services (UHS) director Elliot J. Sussman, M.D., reported insider transactions. On 10/29/2025, he exercised 2,500 options at $138.80 per share (code M), satisfied taxes through the withholding of 1,535 shares at $226.15 (code F), and sold 965 shares at a weighted average price of $225.6981 (code S).
Following these transactions, his directly held Class B common shares were 6,113. The sale price reflects multiple trades between $225.38 and $225.80 as disclosed.
Universal Health Services (UHS)75,000 Class B shares at $138.8 and 90,000 Class B shares at $152.68 (code M). Shares totaling 131,758 were withheld to cover taxes at $225.3 (code F).
After these transactions, Miller directly owned 311,296 Class B shares. He also reported indirect holdings through several family trusts, including stakes in the Abby Danielle Miller 2002 Trust, Abby Miller King 2011 Family Trust, Marc Daniel Miller 2002 and 2011 Family Trusts, and Marni Spencer 2002 and 2011 Family Trusts.
Universal Health Services (UHS) reported insider activity by Executive Chairman, Director and 10% Owner Alan B. Miller. On 10/29/2025, he exercised options (code M) to acquire 70,213 Class B shares at $152.68 and 62,500 Class B shares at $138.8. He also disposed of 105,519 Class B shares (code F) at $227.04.
Following these transactions, Miller directly owned 1,746,031 Class B shares. The filing also lists indirect holdings across several entities, including 55,763 shares by The Abby Miller King 2011 Family Trust and 59,900 shares by The Marc Daniel Miller 2011 Family Trust. The options referenced carry an expiration date of 03/16/2026. The report notes a disclaimer of beneficial ownership for certain indirect holdings.
Universal Health Services (UHS) filed a Form 144 notice for a proposed sale of up to 965 shares of common stock with an aggregate market value of $217,798.67. The filing lists Morgan Stanley Smith Barney LLC as broker and the NYSE as the exchange, with an approximate sale date of 10/29/2025.
The securities were acquired via a stock option exercise paid in cash on 10/29/2025. Shares outstanding were 63,638,690.
Universal Health Services (UHS) furnished an Item 2.02 update, stating it issued a press release on October 27, 2025 regarding results of operations and financial condition. The release is attached as Exhibit 99.1.
The filing also lists the Cover Page Interactive Data File as Exhibit 104 and confirms UHS’s Class B common stock trades on the NYSE under the symbol UHS.
Universal Health Services reported stronger operating results for the quarter and first half of 2025. Net revenues for the three months ended June 30, 2025 were $4.284 billion versus $3.908 billion a year earlier, and net income attributable to UHS was $353.2 million versus $289.2 million, producing basic EPS of $5.49 compared with $4.32 a year ago. For the six months, revenues were $8.384 billion and net income attributable to UHS was $669.9 million, with diluted EPS of $10.23 versus $8.08 in the prior year period.
The balance sheet shows total assets of $14.986 billion and total equity of $7.086 billion at June 30, 2025. Net cash provided by operating activities for the six months was $909.0 million; investing included $505.0 million of capital expenditures; financing used $319.1 million, including $378.5 million of share repurchases and $26.4 million of dividends. Self-insured reserves remain significant ($487 million professional/general liability; $147 million workers’ compensation), and the company disclosed ongoing legal matters including the Cumberland litigation and a confidential settlement that vacated a prior judgment for The Pavilion.
FAQ
What is the current stock price of Univ Health Svc (UHS)?
What is the market cap of Univ Health Svc (UHS)?
